-
ASCO GI Wrap-up: Clinical Updates in Pancreatic Cancer - 14 day(s) ago
Dear readers, While we had few randomized clinical trials in pancreatic adenocarcinoma, this year, we did have several critical updates. First, from Japan, the JCOG1901…
Gastrointestinal Cancers With Zev Wainberg, MD
GastroenterologyDr. Wainberg is an academic medical oncologist at the David Geffen UCLA School of Medicine specializing in gastrointestinal malignancies. He currently serves as the co-director of the GI oncology program, medical director of the Pancreas Cancer Center with a joint appointment in medicine and surgery, and as the director of the Early Phase Clinical Research Program at the Jonsson Comprehensive Cancer Center at UCLA.
-
Reflecting on Pancreatic Cancer at ASCO GI 2025 - 20 day(s) ago
Dear readers, At ASCO GI 2025, we had several updates on novel therapeutics in pancreatic cancer. Dr. Picozzi updated us on the development of pamrevlumab…
-
Noninvasive Biomarkers for the Early Detection of Pancreatic Cancer Presented at ASCO GI 2025 - 24 day(s) ago
Dear readers, We had several updates on trials in pancreas cancer come out yesterday. First, an update became available on the JCOG1901 trial in pancreas…
-
ASCO GI 2025: What I Look Forward to in Pancreatic Cancer - 26 day(s) ago
Dear Colleagues, I am looking forward to several important clinical trials on pancreatic cancer at ASCO GI. Updates by Dr. Vincent Picozzi on Pamrevlumab in…